<Towards the era of 'US-China bipolar' drug discovery> Shock that approximately 40% of anti-cancer drug candidates are 'originated in China', the 'harsh reality' facing the Japanese market | Business | Toyo Keizai Online

From "America's No. 1 power" to "US-China polarization." A major tectonic shift is occurring in the global balance of power in drug discovery. China, along with the United States, has a strong presence in the development of innovative new drugs, and was once the second largest drug discovery country after the United States.